title: A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
authors.affiliation: University of Minnesota, Minneapolis, MN, USA. erin.warshaw@med.va.gov
authors.forename: Erin M
authors.initials: EM
authors.lastname: Warshaw
authors.forename: David
authors.initials: D
authors.lastname: Nelson
authors.forename: Susan M
authors.initials: SM
authors.lastname: Carver
authors.forename: Gary R
authors.initials: GR
authors.lastname: Zielke
authors.forename: Nancy
authors.initials: N
authors.lastname: Webster
authors.forename: Frank A
authors.initials: FA
authors.lastname: Lederle
authors.forename: Debra D
authors.initials: DD
authors.lastname: Fett
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014009:Onychomycosis / Q000188:drug therapy*; D010352:Patient Dropouts; D010865:Pilot Projects; D011537:Pruritus / Q000139:chemically induced; D013045:Species Specificity; D000077291:Terbinafine; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D000077291:Terbinafine